At Sona Group, ophthalmology is one of the areas where we have built strong expertise and long-term partnership with the medical community. As dry eye disease gains greater clinical relevance worldwide, it is also becoming an increasingly important focus in everyday ophthalmic care.
This trend is reinforced by the way people live and work today. With screen time continuing to grow year after year, constant use of digital devices is placing additional strain on eye health and contributing to the growing burden of dry eye disease.
Prevalence ranges from 7.3% in children aged 6-9 years to 31.6% in women aged 20-29 years. Among adults aged 40-80, dry eye disease affects around 20% of men and 30% of women.* These figures reinforce the need for sustained clinical attention, timely diagnosis, and access to trusted treatment options.
Against this background, Sona-Exim continues to strengthen its leadership position in the category in Ukraine**:
• Sona-Exim ranks #1 with the HYLO range in promotion among ophthalmologists in 2025
• Sona-Exim ranks #1 with the HYLO range in the dry eye disease category in Ukraine in 2025
This leadership reflects long-term work in the category, strong engagement with specialists, and a consistent focus on treatment solutions that support individualized care for patients with dry eye disease.
We see this as both a meaningful market result and a clear sign that ophthalmology remains a strategically important area for long-term expertise, partnership, and patient support in Ukraine.
* Source for dry eye disease prevalence: TFOS DEWS III - F. Stapleton, P. Argueso et al., TFOS DEWS III Digest Report, American Journal of Ophthalmology, 2025. DOI: 10.1016/j.ajo.2025.05.040
** Source for market data: Proxima Research, reb TGT HYLO YTD 12.2025
